111 related articles for article (PubMed ID: 1995897)
1. Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents.
Randad RS; Mahran MA; Mehanna AS; Abraham DJ
J Med Chem; 1991 Feb; 34(2):752-7. PubMed ID: 1995897
[TBL] [Abstract][Full Text] [Related]
2. Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats.
Abraham DJ; Wireko FC; Randad RS; Poyart C; Kister J; Bohn B; Liard JF; Kunert MP
Biochemistry; 1992 Sep; 31(38):9141-9. PubMed ID: 1390701
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and investigation of effects of 2-[4- [[(arylamino)carbonyl]amino]phenoxy]-2-methylpropionic acids on the affinity of hemoglobin for oxygen: structure-activity relationships.
Lalezari I; Lalezari P
J Med Chem; 1989 Oct; 32(10):2352-7. PubMed ID: 2795607
[TBL] [Abstract][Full Text] [Related]
4. Effect of an allosteric modifier of hemoglobin, RSR-4, on oxygen affinity and oxygen saturation of hemoglobin in rabbits.
Uchida K; Reilly MP; Abraham DJ; Asakura T
Jpn J Physiol; 1998 Dec; 48(6):439-44. PubMed ID: 10021497
[TBL] [Abstract][Full Text] [Related]
5. High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector.
Safo MK; Moure CM; Burnett JC; Joshi GS; Abraham DJ
Protein Sci; 2001 May; 10(5):951-7. PubMed ID: 11316875
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of chiral allosteric modifiers of hemoglobin.
Phelps Grella M; Danso-Danquah R; Safo MK; Joshi GS; Kister J; Marden M; Hoffman SJ; Abraham DJ
J Med Chem; 2000 Dec; 43(25):4726-37. PubMed ID: 11123981
[TBL] [Abstract][Full Text] [Related]
7. RSR13, a synthetic allosteric modifier of hemoglobin, improves myocardial recovery following hypothermic cardiopulmonary bypass.
Kilgore KS; Shwartz CF; Gallagher MA; Steffen RP; Mosca RS; Bolling SF
Circulation; 1999 Nov; 100(19 Suppl):II351-6. PubMed ID: 10567328
[TBL] [Abstract][Full Text] [Related]
8. Aryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of Hemoglobin.
Omar AM; Mahran MA; Ghatge MS; Bamane FH; Ahmed MH; El-Araby ME; Abdulmalik O; Safo MK
Molecules; 2016 Aug; 21(8):. PubMed ID: 27529207
[TBL] [Abstract][Full Text] [Related]
9. Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo.
Teicher BA; Wong JS; Takeuchi H; Gravelin LM; Ara G; Buxton D
Cancer Chemother Pharmacol; 1998; 42(1):24-30. PubMed ID: 9619754
[TBL] [Abstract][Full Text] [Related]
10. Effects of a synthetic allosteric modifier of hemoglobin oxygen affinity on outcome from global cerebral ischemia in the rat.
Grocott HP; Bart RD; Sheng H; Miura Y; Steffen R; Pearlstein RD; Warner DS
Stroke; 1998 Aug; 29(8):1650-5. PubMed ID: 9707208
[TBL] [Abstract][Full Text] [Related]
11. Preservation of canine myocardial high-energy phosphates during low-flow ischemia with modification of hemoglobin-oxygen affinity.
Weiss RG; Mejia MA; Kass DA; DiPaula AF; Becker LC; Gerstenblith G; Chacko VP
J Clin Invest; 1999 Mar; 103(5):739-46. PubMed ID: 10074492
[TBL] [Abstract][Full Text] [Related]
12. Allosteric modification of oxygen delivery by hemoglobin.
Wahr JA; Gerber M; Venitz J; Baliga N
Anesth Analg; 2001 Mar; 92(3):615-20. PubMed ID: 11226087
[TBL] [Abstract][Full Text] [Related]
13. Effects of RSR13, a synthetic allosteric modifier of hemoglobin, alone and in combination with dizocilpine, on outcome from transient focal cerebral ischemia in the rat.
Sarraf-Yazdi S; Sheng H; Grocott HP; Bart RD; Pearlstein RD; Steffen RP; Warner DS
Brain Res; 1999 May; 826(2):172-80. PubMed ID: 10224294
[TBL] [Abstract][Full Text] [Related]
14. Synthesized allosteric effectors of the hemoglobin molecule: a possible mechanism for improved erythrocyte oxygen release capability in hemoglobinopathy H disease.
Papassotiriou I; Kister J; Griffon N; Abraham DJ; Kanavakis E; Traeger-Synodinos J; Stamoulakatou A; Marden MC; Poyart C
Exp Hematol; 1998 Sep; 26(10):922-6. PubMed ID: 9728926
[TBL] [Abstract][Full Text] [Related]
15. Pyridyl derivatives of benzaldehyde as potential antisickling agents.
Nnamani IN; Joshi GS; Danso-Danquah R; Abdulmalik O; Asakura T; Abraham DJ; Safo MK
Chem Biodivers; 2008 Sep; 5(9):1762-9. PubMed ID: 18816529
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and testing of potential antisickling agents. 4. Structure-activity relationships of benzyloxy and phenoxy acids.
Abraham DJ; Kennedy PE; Mehanna AS; Patwa DC; Williams FL
J Med Chem; 1984 Aug; 27(8):967-78. PubMed ID: 6747995
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic activity at the molecular level: E. J. Ariƫns' concept visualized.
Abraham DJ; Kister J; Joshi GS; Marden MC; Poyart C
J Mol Biol; 1995 May; 248(4):845-55. PubMed ID: 7752245
[TBL] [Abstract][Full Text] [Related]
18. X-ray crystallographic analyses of symmetrical allosteric effectors of hemoglobin: compounds designed to link primary and secondary binding sites.
Safo MK; Boyiri T; Burnett JC; Danso-Danquah R; Moure CM; Joshi GS; Abraham DJ
Acta Crystallogr D Biol Crystallogr; 2002 Apr; 58(Pt 4):634-44. PubMed ID: 11914488
[TBL] [Abstract][Full Text] [Related]
19. How allosteric effectors can bind to the same protein residue and produce opposite shifts in the allosteric equilibrium.
Abraham DJ; Safo MK; Boyiri T; Danso-Danquah RE; Kister J; Poyart C
Biochemistry; 1995 Nov; 34(46):15006-20. PubMed ID: 7578114
[TBL] [Abstract][Full Text] [Related]
20. Quantitative structure-activity relationship of phenoxy and benzyloxy acid derivatives as antisickling agents.
Mahran MA
Boll Chim Farm; 2000; 139(2):73-80. PubMed ID: 10920532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]